Regulation of tie receptor expression on human endothelial cells by protein kinase C-mediated release of soluble tie

Blood

Volumn 90, Issue 2, 1997, Pages 706-715

  Yabkowitz, Rachel ^a   Meyer, Susanne ^a   Yanagihara, Donna ^a   Brankow, David ^a   Staley, Tabitha ^a   Elliott, Gary ^a   Hu, Sylvia ^a   Ratzkin, Barry ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; COLONY STIMULATING FACTOR; PROTEIN KINASE C; STEM CELL FACTOR; TUMOR NECROSIS FACTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL LYSATE; CELL SURFACE; CHO CELL; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030811667     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.2.706.706_706_715     Document Type: Article

References (49)

1. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res 46:467, 1986
2. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27, 1995
3. Brindle NPJ: Growth factors in endothelial regeneration. Cardiovasc Res 27:1162, 1993
4. Van der Geer P, Hunter T, Lindberg R: Receptor protein tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 10:251, 1994
5. Haller H, Lindschau C, Luft FC: Role of protein kinase C in intracellular signaling. Ann N Y Acad Sci 733:313, 1994
6. Downward J, Waterfield MD, Parker PJ: Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity. J Biol Chem 260:14538, 1985
7. Mustonen T, Alitalo, K: Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129:895, 1995
8. Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18, 1992
9. Basilico C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59:145, 1992
10. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4, 1990
11. Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn LM: Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res 56:1615, 1996
12. Takahashi JA, Fukumoto M, Kozai Y, Ito N, Oda Y, Kikuchi H, Hatanaka M: Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factor. FEBS Lett 288:65, 1991
13. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841, 1993
14. Partanen J, Armstrong E, Makela TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K, Alitalo K: A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 12:1698, 1992
15. Batard P, Sansilvestri P, Scheinecker C, Knapp W, Debili N, Vainchenker W, Buring H-J, Monier M-N, Kukk E, Partanen J, Matikainen M-T, Alitalo R, Hatzfeld J, Alitalo K: The tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood 87:2212, 1996
16. Armstrong E, Korhonen J, Silvennoinen O, Cleveland JL, Lieberman MA, Alitalo R: Expression of tie receptor tyrosine kinase in leukemia cell lines. Leukemia 7:1585, 1993
17. Dumont DJ, Fong G-H, Puri MC, Gradwohl G, Alitalo K, Breitman ML: Vascularization of the mouse embryo: A study of flk-1, tek, tie and vascular endothelial growth factor expression during development. Dev Dyn 203:80, 1995
18. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J: The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14:5884, 1995
19. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70, 1995
20. Korhonen J, Partenen J, Armstrong E, Vashtokari A, Elenius K, Jalkanen M, Alitalo K: Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood 80:2548, 1992
21. DeClerck Y, Yean T-D, Lu HS, Ting J, Langley KE: Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J Biol Chem 266:3893, 1991
22. Harlow E, Lane D: Antibodies: A laboratory manual: Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1988
23. Urlaub G, Chasin LA: Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc Natl Acad Sci USA 77:4216, 1980
24. Doctrow SR, Folkman J: Protein kinase C activators suppress stimulation of capillary endothelial cell growth by angiogenic endothelial mitogens. J Cell Biol 104:679, 1987
25. Montesano R, Pepper MS, Vassalli J-D, Orci L: Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors. J Cell Physiol 132:509, 1987
26. Niedbala MJ, Stein-Picarella M: Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator. Blood 81:2608, 1993
27. Sturani E, Zippel R, Toschi L, Morello L, Comoglio PM, Alberghina L: Kinetics and regulation of the tyrosine phosphorylation of epidermal growth factor receptor in intact A431 cells. Mol Cell Biol 8:1345, 1988
28. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029, 1995
29. Hatva E, Kaipainen A, Mentula P, Jaaskelainen J, Paetau A, Haotia M, Alitalo K: Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 146:368, 1995
30. Kaipainen A, Vlaykova T, Hatva E, Bohling T, Jekunen A, Pyrhonen S, Alitalo K: Enhanced expression of the tie receptor tyrosine kinase messenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res 54:6571, 1994
31. Fernandez-Botran R: Soluble cytokine receptors: Their role in immunoregulation. FASEB J 5:2567, 1991
32. Ehlers MRW, Riordan JF: Membrane proteins with soluble counterparts: Role of proteolysis in the release of transmembrane proteins. Biochemistry 30:10065, 1991
33. Downing JR, Roussel MF, Sherr CJ: Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms. Mol Cell Biol 9:2890, 1989
34. Yee NS, Hsiau C-WM, Serve H, Vosseller K, Besmer, P: Mechanism of down-regulation of c-kit receptor. Roles of receptor tyrosine kinase, phophatidylinositol 3′-kinase, and protein kinase C. J Biol Chem 269:31991, 1994
35. O'Bryan JP, Fridell Y-W, Koski R, Varnum B, Liu ET: The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage. J Biol Chem 270:551, 1995
36. Petch LA, Harris J, Raymond VW, Blasband A, Lee DC, Earp HS: A truncated, secreted form of the epidermal growth factor receptor is encoded by an alternatively spliced transcript in normal rat tissue. Mol Cell Biol 10:2973, 1990
37. Kendall RL, Thomas KA: Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90:10705, 1993
38. Adachi S, Tsujimura T, Jippo T, Morimoto M, Isozaki K, Kasugai T, Nomura S Kitamura Y: Inhibition of attachment between cultured mast cells and fibroblasts by phorbol 12-myristate 13-acetate and stem cell factor. Exp Hematol 23:58, 1995
39. Mullberg J, Schooltink H, Stoyan T, Gunther M, Graeve L, Buse G, Mackiewicz A, Heinrich PC, Rose-John S: The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23:473, 1993
40. Massague J, Pandiella A: Membrane-anchored growth factors. Annu Rev Biochem 62:515, 1993
41. Flickinger TW, Maihle NJ, Kung H-J: An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation. Mol Cell Biol 12:883, 1992
42. Basu A, Raghunath M, Bishayee S, Das M: Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: Role of interreceptor interaction in kinase regulation. Mol Cell Biol 9:671, 1989
43. Fernandez-Botran R, Vitetta ES: Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. J Exp Med 174:673, 1991
44. Semenzato G, Foa R, Agostini C, Zambello R, Trentin L, Vinanta F, Benedetti F, Chilosi M, Pizzolo G: High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood 70:396, 1987
45. Symons JA, Wood NC, DiGiovine FS, Duff GW: Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol 141:2612, 1988
46. Greenberg SJ, Marcon L, Hurwitz BJ, Waldmann TA, Nelson DL: Elevated levels of soluble interleukin-2 receptors in multiple sclerosis [letter]. N Engl J Med 319:1019, 1988
47. Gatanaga T, Lentz R, Masunaka I, Tomich J, Jeffes III EWB, Baird M, Granger GA: Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patients. Lymphokine Res 9:225, 1990
48. Aderka D, Engelmann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kushtai G: Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 51:5602, 1991
49. Fanslow WC, Sims JE, Sassenfeld J, Morrissey PJ, Gillis S, Dower SK, Widmer MB: Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor. Science 248:739, 1990